Harding Loevner Portfolio holdings
Harding Loevner is an investment manager that buys stocks from around the world, looking for high-quality, growing companies to hold for the long term. Former managers for the Rockefeller family founded the firm in 1989; Affiliated Managers Group owns most of it, though it operates independently and its key employees hold the rest. A company must show a competitive advantage, quality management, financial strength and sustainable growth before the firm will consider buying it, and individuals rather than committees make the decisions. It offers its strategies through individually managed portfolios, mutual funds and programs run by other financial institutions, for clients such as retirement plans, foundations, endowments and sovereign wealth funds.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
BioNTech
BNTX
|
+$397M |
| 2 |
TSMC
TSM
|
+$192M |
| 3 |
Sony
SONY
|
+$189M |
| 4 |
HDFC Bank
HDB
|
+$137M |
| 5 |
Veralto
VLTO
|
+$28.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE All-World ex-US ETF
VEU
|
+$44.5M |
| 2 |
Danaher
DHR
|
+$36.9M |
| 3 |
Fomento Económico Mexicano
FMX
|
+$33.8M |
| 4 |
BHP
BHP
|
+$20.3M |
| 5 |
Alcon
ALC
|
+$17M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 26.71% |
| 2 | Healthcare | 18.75% |
| 3 | Financials | 14.3% |
| 4 | Communication Services | 9.02% |
| 5 | Industrials | 8.5% |
Similar funds
Harding Loevner's Q4 2023 Portfolio in Review
As of Q4 2023, Harding Loevner held 75 positions worth $17.8B, up 18% from $15.1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Harding Loevner deployed $589M of net new capital in Q4 2023, opening 4 new positions and adding to 8 existing holdings. Its largest new stake was BioNTech: 3,944,474 shares worth $411M.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 24% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Vanguard FTSE All-World ex-US ETF, an estimated $44.5M trimmed.
- Harding Loevner's largest Q4 2023 buy was BioNTech: 3,944,474 shares worth $411M.
- Harding Loevner added most to TSMC in Q4 2023, an estimated $192M increase.
- Harding Loevner's biggest Q4 2023 reduction was Vanguard FTSE All-World ex-US ETF, cutting an estimated $44.5M.
- Harding Loevner fully exited iShares MSCI ACWI ETF in Q4 2023, selling an estimated $2.3M.
- Harding Loevner's ten largest holdings make up 40% of its $17.8B portfolio in Q4 2023.
- Harding Loevner opened 4 new positions and closed 3 in Q4 2023.
- Harding Loevner's portfolio value rose 18% quarter-over-quarter to $17.8B.
Based on Harding Loevner's 13F filing for Q4 2023, filed 14 Feb 2024.